389 related articles for article (PubMed ID: 13129923)
21. Divergent roles of sphingosine kinases in kidney ischemia-reperfusion injury.
Jo SK; Bajwa A; Ye H; Vergis AL; Awad AS; Kharel Y; Lynch KR; Okusa MD
Kidney Int; 2009 Jan; 75(2):167-75. PubMed ID: 18971925
[TBL] [Abstract][Full Text] [Related]
22. Active, phosphorylated fingolimod inhibits histone deacetylases and facilitates fear extinction memory.
Hait NC; Wise LE; Allegood JC; O'Brien M; Avni D; Reeves TM; Knapp PE; Lu J; Luo C; Miles MF; Milstien S; Lichtman AH; Spiegel S
Nat Neurosci; 2014 Jul; 17(7):971-80. PubMed ID: 24859201
[TBL] [Abstract][Full Text] [Related]
23. Involvement of N-terminal-extended form of sphingosine kinase 2 in serum-dependent regulation of cell proliferation and apoptosis.
Okada T; Ding G; Sonoda H; Kajimoto T; Haga Y; Khosrowbeygi A; Gao S; Miwa N; Jahangeer S; Nakamura S
J Biol Chem; 2005 Oct; 280(43):36318-25. PubMed ID: 16103110
[TBL] [Abstract][Full Text] [Related]
24. Sphingosine Kinase 2 Phosphorylation of FTY720 is Unnecessary for Prevention of Light-Induced Retinal Damage.
Qi H; Cole J; Grambergs RC; Gillenwater JR; Mondal K; Khanam S; Dutta S; Stiles M; Proia RL; Allegood J; Mandal N
Sci Rep; 2019 May; 9(1):7771. PubMed ID: 31123291
[TBL] [Abstract][Full Text] [Related]
25. Subcellular distribution of FTY720 and FTY720-phosphate in immune cells - another aspect of Fingolimod action relevant for therapeutic application.
Schröder M; Arlt O; Schmidt H; Huwiler A; Angioni C; Pfeilschifter JM; Schwiebs A; Radeke HH
Biol Chem; 2015 Jun; 396(6-7):795-802. PubMed ID: 25720062
[TBL] [Abstract][Full Text] [Related]
26. Usage of sphingosine kinase isoforms in mast cells is species and/or cell type determined.
Dillahunt SE; Sargent JL; Suzuki R; Proia RL; Gilfillan A; Rivera J; Olivera A
J Immunol; 2013 Mar; 190(5):2058-67. PubMed ID: 23359503
[TBL] [Abstract][Full Text] [Related]
27. FTY720 (fingolimod) sensitizes prostate cancer cells to radiotherapy by inhibition of sphingosine kinase-1.
Pchejetski D; Bohler T; Brizuela L; Sauer L; Doumerc N; Golzio M; Salunkhe V; Teissié J; Malavaud B; Waxman J; Cuvillier O
Cancer Res; 2010 Nov; 70(21):8651-61. PubMed ID: 20959468
[TBL] [Abstract][Full Text] [Related]
28. The sphingosine kinase 1 and S1P1 axis specifically counteracts LPS-induced IL-12p70 production in immune cells of the spleen.
Schröder M; Richter C; Juan MH; Maltusch K; Giegold O; Quintini G; Pfeilschifter JM; Huwiler A; Radeke HH
Mol Immunol; 2011 May; 48(9-10):1139-48. PubMed ID: 21435724
[TBL] [Abstract][Full Text] [Related]
29. Transient inhibition of sphingosine kinases confers protection to influenza A virus infected mice.
Xia C; Seo YJ; Studstill CJ; Vijayan M; Wolf JJ; Hahm B
Antiviral Res; 2018 Oct; 158():171-177. PubMed ID: 30125617
[TBL] [Abstract][Full Text] [Related]
30. FTY720 inhibits tubulointerstitial inflammation in albumin overload-induced nephropathy of rats via the Sphk1 pathway.
Xu M; Liu D; Ding LH; Ma KL; Wu M; Lv LL; Wen Y; Liu H; Tang RN; Liu BC
Acta Pharmacol Sin; 2014 Dec; 35(12):1537-45. PubMed ID: 25399649
[TBL] [Abstract][Full Text] [Related]
31. FTY720 (fingolimod) increases vascular tone and blood pressure in spontaneously hypertensive rats via inhibition of sphingosine kinase.
Spijkers LJ; Alewijnse AE; Peters SL
Br J Pharmacol; 2012 Jun; 166(4):1411-8. PubMed ID: 22251137
[TBL] [Abstract][Full Text] [Related]
32. SphK1 and SphK2, sphingosine kinase isoenzymes with opposing functions in sphingolipid metabolism.
Maceyka M; Sankala H; Hait NC; Le Stunff H; Liu H; Toman R; Collier C; Zhang M; Satin LS; Merrill AH; Milstien S; Spiegel S
J Biol Chem; 2005 Nov; 280(44):37118-29. PubMed ID: 16118219
[TBL] [Abstract][Full Text] [Related]
33. Elimination of a hydroxyl group in FTY720 dramatically improves the phosphorylation rate.
Jary E; Bee T; Walker SR; Chung SK; Seo KC; Morris JC; Don AS
Mol Pharmacol; 2010 Oct; 78(4):685-92. PubMed ID: 20610734
[TBL] [Abstract][Full Text] [Related]
34. Sphk1/S1P/S1PR1 Signaling is Involved in the Development of Autoimmune Thyroiditis in Patients and NOD.H-2
Han C; He X; Xia X; Guo J; Liu A; Liu X; Wang X; Li C; Peng S; Zhao W; Zhou M; Shi X; Li Y; Li Y; Shan Z; Teng W
Thyroid; 2019 May; 29(5):700-713. PubMed ID: 30963819
[No Abstract] [Full Text] [Related]
35. Molecular targets of FTY720 (fingolimod).
Pitman MR; Woodcock JM; Lopez AF; Pitson SM
Curr Mol Med; 2012 Dec; 12(10):1207-19. PubMed ID: 22834825
[TBL] [Abstract][Full Text] [Related]
36. Expression of sphingosine kinase 2 in synovial fibroblasts of rheumatoid arthritis contributing to apoptosis by a sphingosine analogue, FTY720.
Kamada K; Arita N; Tsubaki T; Takubo N; Fujino T; Soga Y; Miyazaki T; Yamamoto H; Nose M
Pathol Int; 2009 Jun; 59(6):382-9. PubMed ID: 19490468
[TBL] [Abstract][Full Text] [Related]
37. Sphingosine kinase type 2 inhibition elevates circulating sphingosine 1-phosphate.
Kharel Y; Raje M; Gao M; Gellett AM; Tomsig JL; Lynch KR; Santos WL
Biochem J; 2012 Oct; 447(1):149-57. PubMed ID: 22747486
[TBL] [Abstract][Full Text] [Related]
38. Rational design of SphK inhibitors using crystal structures aided by computer.
Ding T; Zhi Y; Xie W; Yao Q; Liu B
Eur J Med Chem; 2021 Mar; 213():113164. PubMed ID: 33454547
[TBL] [Abstract][Full Text] [Related]
39. Differential regulation of sphingosine kinases 1 and 2 in lung injury.
Wadgaonkar R; Patel V; Grinkina N; Romano C; Liu J; Zhao Y; Sammani S; Garcia JG; Natarajan V
Am J Physiol Lung Cell Mol Physiol; 2009 Apr; 296(4):L603-13. PubMed ID: 19168577
[TBL] [Abstract][Full Text] [Related]
40. Sphk1 and Sphk2 Differentially Regulate Erythropoietin Synthesis in Mouse Renal Interstitial Fibroblast-like Cells.
Hafizi R; Imeri F; Stepanovska Tanturovska B; Manaila R; Schwalm S; Trautmann S; Wenger RH; Pfeilschifter J; Huwiler A
Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682566
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
